Showing results (181-190 of 250) with videos related to
Sort By:
Pageof 25
Clinical Breast Cancer|November 9, 2019
The Role of CXCL13 and CXCL9 in Early Breast CancerEvangelia Razis, Konstantine T Kalogeras, Ioannis Kotsantis, et al.Future Oncology (London, England)|January 25, 2022
PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrenceAlexander Mm Eggermont, Paolo A Ascierto, Nikhil I Khushalani, et al.Breast Cancer Research and Treatment|April 25, 2007
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patientsIrene Konstantopoulou, Theodore Rampias, Angela Ladopoulou, et al.Journal of Translational Medicine|January 14, 2012
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapyGeorge Fountzilas, Christos Valavanis, Vassiliki Kotoula, et al.Breast Cancer Research and Treatment|March 22, 2012
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group StudyFlorentia Fostira, Marianthi Tsitlaidou, Christos Papadimitriou, et al.Breast Cancer Research and Treatment|March 16, 2006
Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapyIoannis Kostopoulos, Petroula Arapantoni-Dadioti, Helen Gogas, et al.Anticancer Research|May 29, 2017
The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant ChemotherapyTheofani Gavressea, Konstantine T Kalogeras, Georgia-Angeliki Koliou, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|August 12, 2018
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortiumAlexander J Stratigos, Maria Concetta Fargnoli, Arcangela De Nicolo, et al.Plos One|October 4, 2016
Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group StudyFlora Stavridi, Konstantine T Kalogeras, Kyriaki Pliarchopoulou, et al.Breast Cancer Research and Treatment|December 22, 2011
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III TrialHelen Gogas, Urania Dafni, Maria Karina, et al.Pageof 25